Review: taking Sertraline and Meloxicam together


Summary

Drug interactions are reported among people who take Sertraline and Meloxicam together. This review analyzes the effectiveness and drug interactions between Sertraline and Meloxicam. It is created by eHealthMe based on reports of 1,440 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Sertraline

Sertraline has active ingredients of sertraline hydrochloride. It is often used in depression. (latest outcomes from Sertraline 46,905 users)

Meloxicam

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. (latest outcomes from Meloxicam 20,232 users)

On Sep, 14, 2016

1,440 people who take Sertraline, Meloxicam are studied.


Number of reports submitted per year:

Sertraline and Meloxicam drug interactions.

Drug effectiveness over time:

Sertraline:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 28.0% - (4 of 14 people)
  • 6 - 12 months: 0.0% - (0 of 7 people)
  • 1 - 2 years: 57.0% - (4 of 7 people)
  • 2 - 5 years: 60.0% - (14 of 23 people)
  • 5 - 10 years: 60.0% - (6 of 10 people)
  • 10+ years: 33.0% - (2 of 6 people)
  • not specified: 0.0% - (0 of 0 people)
Meloxicam:
  • < 1 month: 16.0% - (2 of 12 people)
  • 1 - 6 months: 33.0% - (3 of 9 people)
  • 6 - 12 months: 41.0% - (5 of 12 people)
  • 1 - 2 years: 42.0% - (3 of 7 people)
  • 2 - 5 years: 40.0% - (6 of 15 people)
  • 5 - 10 years: 50.0% - (2 of 4 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 1 people)

Drug effectiveness by gender:

Sertraline:
  • female: 48.0% - (27 of 56 people)
  • male: 23.0% - (3 of 13 people)
Meloxicam:
  • female: 34.0% - (18 of 52 people)
  • male: 50.0% - (6 of 12 people)

Drug effectiveness by age:

Sertraline:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 66.0% - (2 of 3 people)
  • 30-39: 25.0% - (2 of 8 people)
  • 40-49: 38.0% - (7 of 18 people)
  • 50-59: 55.0% - (11 of 20 people)
  • 60+: 40.0% - (8 of 20 people)
Meloxicam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 33.0% - (1 of 3 people)
  • 30-39: 25.0% - (2 of 8 people)
  • 40-49: 35.0% - (6 of 17 people)
  • 50-59: 52.0% - (9 of 17 people)
  • 60+: 31.0% - (6 of 19 people)

Most common drug interactions over time *:

< 1 month:
  • agitation
  • convulsion
  • confusional state
  • diarrhoea
  • abdominal pain
  • dizziness
  • drug ineffective
  • gait disturbance
  • hyperhidrosis
  • hypertension
1 - 6 months:
  • constipation
  • mental status changes
  • asthenia
  • cerebrovascular accident
  • dysarthria
  • faecal incontinence
  • fall
  • gait disturbance
  • hallucination
  • hyperkalaemia
6 - 12 months:
  • dry mouth
  • eye swelling
  • headache
  • itching
  • sleepiness
  • tinnitus aggravated
  • cardiomegaly
  • choledochal cyst
  • cyanosis neonatal
  • neonatal respiratory distress syndrome
1 - 2 years:
  • short-term memory loss
  • arthritis
  • activities of daily living impaired
  • cleft palate
  • congenital anomaly
  • congenital eye disorder
  • dyspnoea
  • feeding disorder
  • foetal damage
  • gait disturbance
2 - 5 years:
  • headache
  • tinnitus aggravated
  • drug screen false positive
  • short-term memory loss
  • intranasal numbness
  • nausea
  • depression
  • dizziness
  • long-term memory loss
  • pain exacerbated
5 - 10 years:
  • drug screen false positive
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • fatigue aggravated
  • fibromyalgia
  • heat exhaustion
  • hot flushes aggravated
  • joint sprain
  • long-term memory loss
  • lower blood pressure
  • pain
10+ years:
  • sinusitis
  • cardiac disorder
  • cough
  • dyspepsia
  • fatigue
  • gallbladder disorder
  • gastrointestinal disorder
  • pain
  • ammonia increased
  • cholelithiasis
not specified:
  • pain
  • anxiety
  • dyspnoea
  • nausea
  • headache
  • fall
  • anaemia
  • back pain
  • spinal osteoarthritis
  • fatigue

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • dyspnoea
  • fall
  • nausea
  • arthralgia
  • fatigue
  • back pain
  • oedema peripheral
  • pain in extremity
male:
  • pain
  • nausea
  • dyspnoea
  • headache
  • chest pain
  • anxiety
  • death
  • atelectasis
  • pancreatitis
  • cardiomegaly

Most common drug interactions by age *:

0-1:
  • blood cholesterol increased
  • gallbladder operation
  • sensation of foreign body
  • type 2 diabetes mellitus
  • drug exposure via breast milk
  • rash
  • urticaria
2-9:
  • abdominal pain upper
  • dyspnoea
  • hyperkalaemia
  • splenic infarction
  • thrombotic thrombocytopenic purpura
  • overdose
  • pyrexia
  • rash
  • somnolence
  • swelling
10-19:
  • death
  • pain
  • endocarditis
  • osteomyelitis
  • depression
  • hallucination, auditory
  • myalgia
  • apnoea
  • cardiac arrest
  • cardio-respiratory arrest
20-29:
  • depression
  • anxiety
  • deep vein thrombosis
  • pain
  • nausea
  • vomiting
  • dyspnoea
  • pulmonary embolism
  • abdominal pain
  • suicidal ideation
30-39:
  • pain
  • dyspepsia
  • fatigue
  • knee pain
  • arthralgia
  • pulmonary embolism
  • abdominal pain
  • dyspnoea
  • headache
  • hypoaesthesia
40-49:
  • headache
  • pain
  • cardiomegaly
  • choledochal cyst
  • cyanosis neonatal
  • neonatal respiratory distress syndrome
  • pulmonary artery atresia
  • pulmonary valve stenosis
  • tricuspid valve incompetence
  • ventricular septal defect
50-59:
  • pain
  • arthralgia
  • anxiety
  • oedema peripheral
  • impaired healing
  • muscular weakness
  • pyrexia
  • constipation
  • back pain
  • spinal osteoarthritis
60+:
  • pain
  • anxiety
  • nausea
  • pain in jaw
  • dyspnoea
  • headache
  • dental caries
  • inflammation
  • anaemia
  • weight decreased

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Sertraline and Meloxicam?

Can you answer these questions?

More questions for: Sertraline, Meloxicam

You may be interested in these reviews

More reviews for: Sertraline, Meloxicam

On eHealthMe, Sertraline (sertraline hydrochloride) is often used to treat depression. Meloxicam (meloxicam) is often used to treat arthritis. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.